Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers
Slávka Hamuľaková(University of Pavol Jozef Šafárik), Kamil Kuča(University Hospital Hradec Králové), Mária Kožurková(Institute of Chemistry of the Slovak Academy of Sciences), Pavol Kristián(Evotec (United States)), Stanislav Böhm(University of Chemistry and Technology, Prague), Miroslav Pohanka(University of Defence), Ivan Danihel, Ladislav Janovec, Ján Imrich, Ondřej Holas(Charles University)
Cited by 43
Related Papers
Insect Antimicrobial Peptides, a Mini Review
|Toxins|2018|472
CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY
|Biomedical Papers|2011|373
The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2
|Journal of Viral Hepatitis|2015|125
Synthesis and Biological Evaluation of Novel Tacrine Derivatives and Tacrine–Coumarin Hybrids as Cholinesterase Inhibitors
|Journal of Medicinal Chemistry|2014|112
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2
|Journal of Viral Hepatitis|2015|93